Streetbeat News

Analyst Ratings

BBY

NTNX

NVDA

SPLK

YOU

Five of Wall Street's most accurate analysts have made new stock picks, with potential upsides ranging from 1% to 24%. The picks include Best Buy, Clear Secure, Nvidia, Nutanix, and Splunk, all of which have recently reported better-than-expected financial results.

Portfolio Pulse from Lisa Levin

May 30, 2023 | 11:05 am

KVUE

B of A Securities analyst Anna Lizzul initiates coverage on Kenvue (NYSE:KVUE) with a Buy rating and announces a price target of $30.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:05 am

STE

Morgan Stanley analyst Patrick Wood initiates coverage on Steris (NYSE:STE) with an Equal-Weight rating and a price target of $206.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:04 am

COO

Morgan Stanley analyst Patrick Wood initiates coverage on Cooper Companies (NYSE:COO) with an Equal-Weight rating and announces a price target of $410.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:03 am

CMPS

EF Hutton analyst Elemer Piros reiterates a Buy rating on Compass Pathways (NASDAQ:CMPS) and maintains a $38 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:03 am

NSP

Baird analyst Mark Marcon maintains a Neutral rating on Insperity (NYSE:NSP) and lowers the price target from $131 to $120.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:01 am

HIBB

Baird analyst Peter Benedict maintains an Outperform rating on Hibbett (NASDAQ:HIBB) but lowers the price target from $70 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:00 am

CHPT

B of A Securities analyst Alex Vrabel upgraded ChargePoint Holdings (NYSE:CHPT) from Neutral to Buy, but lowered the price target from $15.5 to $14.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 11:00 am

LECO

Baird analyst Mircea Dobre maintains an Outperform rating on Lincoln Electric Holdings (NASDAQ:LECO) and raises the price target from $184 to $200.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:00 am

ELEV

SVB Securities analyst Andrew Berens upgrades Elevation Oncology (NASDAQ:ELEV) from Market Perform to Outperform and raises the price target from $5 to $8.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:59 am